Pulse Biosciences's total assets for Q3 2024 were $93.05M, an increase of 130.15% from the previous quarter. PLSE total liabilities were $13.91M for the fiscal quarter, a 3.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.